These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3814727)

  • 21. Bioassay of Styrene for Possible Carcinogenicity (CAS No.100-42-5).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1979; 185():1-107. PubMed ID: 12778193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers.
    Miller BA; Scoppa SM; Feuer EJ
    Cancer; 2006 Feb; 106(3):670-82. PubMed ID: 16388524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
    Gaylor DW; Swirsky Gold L
    Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Gart JJ; Tarone RE
    Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of diesel-exhaust unit-risk estimates derived from animal bioassays.
    Valberg PA; Watson AY
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):30-44. PubMed ID: 8921544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An age-adjusted bootstrap-based Poly-k test.
    Moon H; Ahn H; Kodell RL
    Stat Med; 2005 Apr; 24(8):1233-44. PubMed ID: 15573413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Weibull model for the estimation of tumorigenic potency.
    Dewanji A; Krewski D; Goddard MJ
    Biometrics; 1993 Jun; 49(2):367-77. PubMed ID: 8369373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Madarnas P; Elhilali M
    Cancer Res; 1983 Feb; 43(2):617-22. PubMed ID: 6848183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing for a trend in tumor prevalence rates: I. Nonlethal tumors.
    Dinse GE
    Biometrics; 1985 Sep; 41(3):751-70. PubMed ID: 4074825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug.
    Iatropoulos MJ; Wang CX; von Keutz E; Williams GM
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):397-404. PubMed ID: 16616835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of C.I. Disperse Blue 1 (A commercial dye containing approximately 50% 1,4,5,8-tetraaminoanthraquinone, and 20% water) (CAS No. 2475-45-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 May; 299():1-241. PubMed ID: 12748707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
    Guess H; Crump K; Peto R
    Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
    [No Abstract]   [Full Text] [Related]  

  • 36. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating tumor incidence rates in animal carcinogenicity experiments.
    Dinse GE
    Biometrics; 1988 Jun; 44(2):405-15. PubMed ID: 3390506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply to Gaylor. Data for high dose and low dose that do not visually fall near a line representing the other data.
    Waddell WJ
    Toxicol Pathol; 2003; 31(6):711. PubMed ID: 14585741
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of statistics when examining lifetime studies in rodents to detect carcinogenicity.
    Salsburg DS
    J Toxicol Environ Health; 1977 Nov; 3(4):611-28. PubMed ID: 592429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.